Today: 20 March 2026
Subscribe
Browse Category

ASX:ORI 12 November 2025 - 14 December 2025

Orica Limited (ASX: ORI) Share Price After the Bell 12 December 2025: Key News, Forecasts and What to Watch Before the Next Market Open

Orica Limited (ASX: ORI) Share Price After the Bell 12 December 2025: Key News, Forecasts and What to Watch Before the Next Market Open

Orica (ASX: ORI) closed at A$23.65 on 12 Dec 2025, up 1% from the previous session, with 2.95 million shares traded. The stock is up about 42% year-to-date and sits near its 52-week high. Materials led gains on the ASX, boosting sentiment for mining-linked stocks. Investors are watching upcoming AGM and dividend dates.
13 December 2025
··
Westpac’s $7 Billion Windfall Ignites ASX Rally Despite Mining Slump – Nov 3, 2025

ASX Today: Australian Shares Slip 0.5% as Jobs Beat Cools Rate‑Cut Hopes; Xero Sinks, Domino’s & Lithium Surge — 13 November 2025

Australia’s S&P/ASX 200 fell 0.52% to 8,753.40 Thursday, hitting a 50-day low after jobs data showed unemployment at 4.3% and 42,200 jobs added in October. The surprise cut rate-cut bets and lifted the Australian dollar. Materials outperformed, while rate-sensitive sectors lagged. DroneShield plunged 31.4% after director share sales; Domino’s jumped 11.6% on an AGM update.
13 November 2025
········
Westpac’s $7 Billion Windfall Ignites ASX Rally Despite Mining Slump – Nov 3, 2025

ASX Pre‑Open: Futures Point Higher as Dow Hits New Record; Oil Slumps, Gold Holds Firm; Jobs Data, Xero, Orica & GrainCorp in Focus (13 Nov 2025)

ASX 200 futures rose 0.15% ahead of Thursday’s open, following a record Dow Jones close above 48,000 and weaker tech stocks on Wall Street. Oil prices dropped to three-week lows, with WTI at US$58.49 a barrel. Investors await Australia’s October labour force report at 11:30am AEDT and earnings from Xero, Orica, and GrainCorp. The Australian dollar traded near US$0.654 early.
12 November 2025
·····

Stock Market Today

  • Regeneus Ltd (RGS.AX) Jumps 33% on Heavy Volume, Signals Short-Term Upside
    March 19, 2026, 10:42 PM EDT. Regeneus Ltd (RGS.AX) surged 33.33% to A$0.012 on March 20, 2026, driven by unusually heavy volume of 4.28 million shares, nearly seven times the average. The stock broke above its 50-day and 200-day moving averages, indicating increased short-term trader interest in this clinical-stage biotech focused on osteoarthritis and wound healing. Despite negative earnings per share and liquidity constraints, the price action reflects momentum trading in a volatile sector. Traders should watch intraday support at A$0.010 and resistance near the year high of A$0.020. With a Meyka AI rating of 64.90 (Grade B), the stock is rated HOLD amid high volatility and thin order books typical of small-cap biotechs on the Australian Securities Exchange (ASX).
Go toTop